Cellebrite DI (CLBT) Shares Outstanding (Diluted Average) (2019 - 2025)

Cellebrite DI has reported Shares Outstanding (Diluted Average) over the past 7 years, most recently at $249.9 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $249.9 million for Q4 2025, up 19.3% from a year ago — trailing twelve months through Dec 2025 was $249.9 million (up 19.3% YoY), and the annual figure for FY2025 was $249.9 million, up 19.3%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $249.9 million at Cellebrite DI, up from $209.5 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for CLBT hit a ceiling of $249.9 million in Q4 2025 and a floor of $161.5 million in Q4 2021.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $195.4 million (2022), compared with a mean of $201.3 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): surged 30.59% in 2021 and later decreased 2.68% in 2023.
  • Cellebrite DI's Shares Outstanding (Diluted Average) stood at $161.5 million in 2021, then rose by 20.96% to $195.4 million in 2022, then decreased by 2.68% to $190.2 million in 2023, then grew by 10.16% to $209.5 million in 2024, then rose by 19.3% to $249.9 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $249.9 million (Q4 2025), $209.5 million (Q4 2024), and $190.2 million (Q4 2023) per Business Quant data.